Skip to the page

Data / Form D filings / Amalgam Rx, Inc.

Amalgam Rx, Inc.: Form D filings

Amalgam Rx, Inc., a health care company in Wilmington, DE, filed 7 Form D notices with the SEC between 2016 and 2025. The latest, on August 15, 2025, reports $7.9 million sold of a $7.9 million offering to 28 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
206 ALAPOCAS DRIVE, Wilmington, DE, 19803
Phone
(302) 983-0001
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1667234

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 15, 2025New notice$7,886,530$7,886,53028Aug 8, 2025sec.gov
Jan 3, 2023New notice$45,000,000$17,365,000$27,635,00062Dec 16, 2022sec.gov
Oct 8, 2019New notice$750,000$650,000$100,0005Sep 23, 2019sec.gov
May 3, 2019Amendment$2,000,000$1,223,886$776,11427Jun 16, 2017sec.gov
Mar 6, 2019Amendment$2,000,000$998,044$1,001,95620Jun 16, 2017sec.gov
Jun 30, 2017New notice$2,000,000$95,000$1,905,0003Jun 16, 2017sec.gov
Mar 24, 2016New notice$500,000$215,000$285,0007Mar 14, 2016sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
SONNY P. VUDirector
JEFFREY P. COURTNEYDirector
RYAN A. SYSKOExecutive Officer, Director

Other health care companies in Delaware that filed recently

Every Form D from the week of Aug 11, 2025 · All recent filings in Delaware · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Amalgam Rx, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.